Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × sonelokimab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

pembrolizumab 156 Carboplatin 122 Paclitaxel 83 Cisplatin 78 Gemcitabine 69 Pemetrexed 64 Bevacizumab 59 Cyclophosphamide 48 Docetaxel 45 Oxaliplatin 41 Fluorouracil 39 Dexamethasone 38 durvalumab 37 Nivolumab 36 Fulvestrant 36 Capecitabine 35 Cetuximab 34 130-nm albumin-bound paclitaxel 34 Lenalidomide 33 Leucovorin 31 atezolizumab 30 fludarabine 29 Rituximab 29 Prednisone 27 venetoclax 26 Trastuzumab 24 Letrozole 22 Doxorubicin 22 ribociclib 20 enzalutamide 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06641089 2026-03-11

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡